ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EWTX Edgewise Therapeutics Inc

33.00
0.80 (2.48%)
29 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -18.26M-22.08M-25.7M-25.34M-29.45M-33.86M-34.75M-38.11M
Pre Tax Income -17.5M-19.42M-22.84M-21.47M-25.71M-30.14M-28.53M-31.5M
Net Income -17.5M-19.42M-22.84M-21.47M-25.71M-30.14M-28.53M-31.5M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -18.26M-22.08M-25.7M-25.34M-29.45M-33.86M-34.75M-38.11M
EBITDA -18.16M-21.99M-25.51M-24.92M-29M-33.38M-34.28M-37.63M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -9.92M-17.19M-43.22M-71.66M-114.36M
Pre Tax Income -9.71M-17.12M-42.81M-67.64M-100.16M
Net Income -9.71M-17.12M-42.81M-67.64M-100.16M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -23.162-16.97-0.865-1.069-1.578
EBIT -9.92M-17.19M-43.22M-71.66M-114.36M
EBITDA -9.8M-17.01M-42.94M-71.29M-112.81M